DK2241616T3 - Immunitetsforbedrende mælkesyrebakterier - Google Patents

Immunitetsforbedrende mælkesyrebakterier

Info

Publication number
DK2241616T3
DK2241616T3 DK10163944.1T DK10163944T DK2241616T3 DK 2241616 T3 DK2241616 T3 DK 2241616T3 DK 10163944 T DK10163944 T DK 10163944T DK 2241616 T3 DK2241616 T3 DK 2241616T3
Authority
DK
Denmark
Prior art keywords
immune
lactic acid
acid bacteria
enhancing lactic
enhancing
Prior art date
Application number
DK10163944.1T
Other languages
English (en)
Inventor
Harsharnjit S Gill
John B Smart
Pramod K Gopal
Original Assignee
New Zealand Dairy Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO8699A external-priority patent/AUPO869997A0/en
Priority claimed from AUPP3225A external-priority patent/AUPP322598A0/en
Application filed by New Zealand Dairy Board filed Critical New Zealand Dairy Board
Application granted granted Critical
Publication of DK2241616T3 publication Critical patent/DK2241616T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/23—Lactobacillus acidophilus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Seasonings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK10163944.1T 1997-08-21 1998-08-18 Immunitetsforbedrende mælkesyrebakterier DK2241616T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO8699A AUPO869997A0 (en) 1997-08-21 1997-08-21 Immuno-enhancing composition
AUPP3225A AUPP322598A0 (en) 1998-04-28 1998-04-28 Immunity-enhancing lactic acid bacteria
EP98941942A EP1007625B1 (en) 1997-08-21 1998-08-18 Immunity enhancing lactic acid bacteria

Publications (1)

Publication Number Publication Date
DK2241616T3 true DK2241616T3 (da) 2013-02-18

Family

ID=25645584

Family Applications (2)

Application Number Title Priority Date Filing Date
DK98941942.9T DK1007625T3 (da) 1997-08-21 1998-08-18 Immunitetsforstærkede mællkesyrebakterie
DK10163944.1T DK2241616T3 (da) 1997-08-21 1998-08-18 Immunitetsforbedrende mælkesyrebakterier

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK98941942.9T DK1007625T3 (da) 1997-08-21 1998-08-18 Immunitetsforstærkede mællkesyrebakterie

Country Status (22)

Country Link
US (1) US6379663B1 (da)
EP (2) EP2241616B1 (da)
JP (1) JP3694236B2 (da)
KR (1) KR100406344B1 (da)
CN (1) CN1150314C (da)
AU (1) AU727940B2 (da)
BR (1) BR9811332A (da)
DE (1) DE69841826D1 (da)
DK (2) DK1007625T3 (da)
ES (2) ES2399324T3 (da)
GB (1) GB2338245B (da)
HK (1) HK1024719A1 (da)
HU (1) HU228046B1 (da)
ID (1) ID24734A (da)
MY (1) MY116272A (da)
NZ (1) NZ337520A (da)
PL (1) PL195110B1 (da)
RU (1) RU2208632C2 (da)
SK (1) SK283008B6 (da)
TR (1) TR200000451T2 (da)
TW (1) TW587098B (da)
WO (1) WO1999010476A1 (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1007625T3 (da) * 1997-08-21 2010-11-01 New Zealand Dairy Board Immunitetsforstærkede mællkesyrebakterie
EP1034788A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
ES2155782B1 (es) * 1999-05-07 2002-05-16 Danone Sa Utilizacion de bacterias acidolacticas pra preparar leches fermentadas para el tratamiento de niveles de actividad inmunitaria transitoriamente reducidos.
ES2155783B1 (es) * 1999-05-07 2002-05-16 Danone Sa Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.
DE60018919T2 (de) * 1999-05-07 2006-05-18 Compagnie Gervais Danone Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen
US7125698B2 (en) * 1999-08-09 2006-10-24 Matthew Glenn Polynucleotides, materials incorporating them, and methods for using them
HU227086B1 (en) 1999-11-25 2010-06-28 Vakcina Kft Lactobacillus vaccine for treating prostata inflammatory and benign prostata hyperplasia
FR2809312B1 (fr) 2000-05-25 2002-07-12 Gervais Danone Sa Utilisation de l. casei dans des compositions immunostimulantes
TW588109B (en) * 2000-07-29 2004-05-21 Tcell Biotechnology Food Co Lt Lactobacillus rhamnosus strain and uses thereof
JP2004505632A (ja) * 2000-08-08 2004-02-26 ジェネシス　リサーチ　アンド　デベロップメント　コーポレイション　リミテッド ラムノスス乳酸菌のポリヌクレオチド及びポリペプチド並びにこれらの使用方法
SG97174A1 (en) * 2000-12-19 2003-07-18 Cell Biotechnology Food Co Ltd Lactobacillus rhamnosus strain and uses thereof
FI109602B (fi) 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
US20030017192A1 (en) * 2001-06-19 2003-01-23 Hanny Kanafani Process for producing extended shelf-life ready-to-use milk compositions containing probiotics
KR100442205B1 (ko) * 2002-02-28 2004-07-30 주식회사 비피도 β- 글루코시다제를 생산하는 비피도박테리움 락티스 및이를 이용하여 이소플라본을 이소플라본 비배당체로전환하는 방법
US20040047849A1 (en) * 2002-09-11 2004-03-11 Genmont Biotech Inc. Use of some lactobacillus strains in treating allergy
NZ521836A (en) * 2002-10-08 2005-07-29 New Zealand Dairy Board High pressure treatment to reduce microbial spoilage in cultured dairy foods, cooked meats, vegetables and the like
US7740838B2 (en) * 2002-12-05 2010-06-22 Danisco A/S Bacterial composition and its use
US7001756B1 (en) * 2004-02-19 2006-02-21 Genmont Biotech Inc. Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity
US6994848B2 (en) * 2004-03-25 2006-02-07 Genmont Biotech Inc. Lactobacillus paracasei strain GM-080 for treating allergy related diseases
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
RU2270248C1 (ru) * 2004-12-31 2006-02-20 Открытое акционерное общество "Лианозовский молочный комбинат" Штамм бифидобактерий bifidobacterium lactis 668, используемый для приготовления кисломолочных, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, бактериальных препаратов и косметических средств
PL1724340T3 (pl) * 2005-05-11 2009-08-31 Chr Hansen As Szczepy bakterii kwasu mlekowego wrażliwe na antybiotyk
RU2394911C2 (ru) * 2005-05-11 2010-07-20 Кр. Хансен А/С Новые чувствительные к антибиотикам штаммы молочнокислых бактерий
JP2007028920A (ja) * 2005-07-22 2007-02-08 Japan Research & Development Association For New Functional Foods 発酵乳およびその製造方法
KR20080059581A (ko) 2005-10-13 2008-06-30 메이지 세이카 가부시키가이샤 장내 플로라 개선용 조성물
US8226936B2 (en) * 2006-11-15 2012-07-24 Chr-Hansen A/S Tetracycline-sensitive bifidobacteria strains
TWI356680B (en) 2007-01-05 2012-01-21 Promd Biotech Co Ltd Anti-allergy lactic acid bacteria
FR2928935B1 (fr) * 2008-03-19 2011-05-20 Gervais Danone Sa Souche de lactobacillus rhamnosus.
SG194345A1 (en) * 2008-09-19 2013-11-29 Nestec Sa Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment
MX2011005527A (es) * 2008-11-28 2011-09-28 Univ Otago Uso de la bacteria de acido lactico para tratar o prevenir el eczema.
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
ES2569241T5 (es) * 2010-01-19 2019-09-11 Abbott Lab Una composición que comprende Lactobacillus rhamnosus HN001 y prebióticos para su uso en el tratamiento de la enfermedad pulmonar alérgica
WO2011141762A1 (en) 2010-05-12 2011-11-17 Compagnie Gervais Danone Synergistic fermentation of lactobacillus rhamnosus and lactobacillus paracasei subsp paracasei
WO2012063345A1 (ja) * 2010-11-11 2012-05-18 株式会社カザミ 免疫賦活剤及びそれを配合した免疫賦活組成物、並びに免疫賦活方法
RU2453591C1 (ru) * 2011-04-21 2012-06-20 Общество с ограниченной ответственностью "Бифилюкс" Штамм lactobacillus rhamnosus, используемый для получения продукции, содержащей лактобактерии
WO2013101516A1 (en) 2011-12-29 2013-07-04 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using extracted genomic dna
ITRM20130174A1 (it) * 2013-03-22 2014-09-23 Eurospital S P A Ceppo di lactobacillus e suo uso come probiotico
RU2019105567A (ru) * 2016-07-28 2020-08-28 Фонтерра Ко-Оперэйтив Груп Лимитед Молочный продукт и способ
EP4136985A1 (en) 2016-12-22 2023-02-22 University of Otago Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
KR102513639B1 (ko) * 2016-12-22 2023-03-23 유니버시티 오브 오타고 임신성 진성 당뇨병의 처치 또는 예방을 위한 락트산 박테리아의 용도
AU2017416677B2 (en) 2017-06-02 2022-09-29 University Of Otago Use of lactic acid bacteria to treat or prevent at least one of postnatal depression and postnatal anxiety
KR20230085712A (ko) 2021-12-07 2023-06-14 주식회사 에이스브이 버터플라이 밸브용 디스크 락킹 장치

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0614862B2 (ja) 1987-05-22 1994-03-02 東京田辺製薬株式会社 ビフィドバクテリウム菌の増殖促進剤
JP2617758B2 (ja) * 1988-03-25 1997-06-04 株式会社ヤクルト本社 抗体産生増強型免疫賦活剤
JPH0551321A (ja) * 1991-08-23 1993-03-02 Yotsuba Nyugyo Kk 免疫賦活剤
DE69219768T2 (de) * 1992-07-06 1997-08-28 Nestle Sa Milchbakterien
CA2156859A1 (en) 1993-02-24 1994-09-01 Sherwood L. Gorbach Method of enhancing immune response to oral vaccines
WO1994026114A1 (en) * 1993-05-11 1994-11-24 Immunom Technologies, Inc. Method of stimulating and modulating the immune system of animals with microbial compositions
JP4112021B2 (ja) * 1994-02-16 2008-07-02 明治乳業株式会社 乳酸菌を用いた免疫賦活剤
JPH092959A (ja) * 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
FI102298B (fi) * 1995-09-07 1998-11-13 Oulutech Oy Menetelmä maitohappobakteerilajien määrittämiseksi ja menetelmään sove ltuvia oligonukleotideja
WO1998023727A1 (en) 1996-11-29 1998-06-04 Bio K + International Inc. Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof
DK1007625T3 (da) * 1997-08-21 2010-11-01 New Zealand Dairy Board Immunitetsforstærkede mællkesyrebakterie

Also Published As

Publication number Publication date
GB2338245B (en) 2001-11-21
EP2241616A1 (en) 2010-10-20
TW587098B (en) 2004-05-11
DE69841826D1 (de) 2010-09-23
GB2338245A (en) 1999-12-15
US6379663B1 (en) 2002-04-30
ID24734A (id) 2000-08-03
HUP0002949A2 (hu) 2000-12-28
SK2192000A3 (en) 2000-09-12
ES2399324T3 (es) 2013-03-27
AU727940B2 (en) 2001-01-04
KR20010023117A (ko) 2001-03-26
KR100406344B1 (ko) 2003-11-19
JP3694236B2 (ja) 2005-09-14
EP1007625A1 (en) 2000-06-14
AU9009598A (en) 1999-03-16
GB9920043D0 (en) 1999-10-27
WO1999010476A1 (en) 1999-03-04
BR9811332A (pt) 2000-09-19
EP1007625B1 (en) 2010-08-11
TR200000451T2 (tr) 2000-06-21
HUP0002949A3 (en) 2003-03-28
CN1264422A (zh) 2000-08-23
HK1024719A1 (en) 2000-10-20
US20020031503A1 (en) 2002-03-14
MY116272A (en) 2003-12-31
PL195110B1 (pl) 2007-08-31
JP2001513990A (ja) 2001-09-11
NZ337520A (en) 2000-01-28
DK1007625T3 (da) 2010-11-01
ES2349669T3 (es) 2011-01-10
HU228046B1 (en) 2013-03-28
EP1007625A4 (en) 2004-12-01
SK283008B6 (sk) 2003-01-09
CN1150314C (zh) 2004-05-19
RU2208632C2 (ru) 2003-07-20
PL338775A1 (en) 2000-11-20
EP2241616B1 (en) 2012-11-28

Similar Documents

Publication Publication Date Title
DK2241616T3 (da) Immunitetsforbedrende mælkesyrebakterier
DE69708658D1 (de) Milchsäurebakterien enthaltendes getrocknetes nahrungsmittel
DE69729021D1 (de) Flächiges Implantat
DE69814070T2 (de) Sterilisationsverfahren
DE69517721D1 (de) Milchsäurebakterien der Gattung Lactobacillus
ATE501640T1 (de) Inkorporation von exogenen milchsäurebakterien in die mikroflora
IL134410A0 (en) Novel lactic acid bacteria
DE69735754D1 (de) Impedanz-abhängiger implantierbarer kardiovertierer defribillator
NO985937D0 (no) Dentalt implantatsystem med forbedret stabilitet
DE60026918D1 (de) Plattenlaufwerksystem
DK0975774T3 (da) Bakterielle plasmider
DE59806033D1 (de) Milchsäurepolymerisate
ATA40797A (de) Implantat
NO20021349D0 (no) Transformerte melkesyrebakterier
ATE293931T1 (de) Implantsystem
DE29713262U1 (de) Dachbodenlift
PT1026044E (pt) Conjunto de atravessamento de divisoria
DE29709725U1 (de) Implantat
KR980004324U (ko) 의료용 가습기
KR970053643U (ko) 냄새 먹는 박테리아를 이용한 탈취기
DE69828009D1 (de) Antriebssystem
DK9700124U4 (da) Patienthjælpelift
KR960024006U (ko) 살균 가습기
KR960024007U (ko) 살균 가습기
FI974120A0 (fi) Lager med laong livslaengd